Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
FLORA: FMT in Advanced HCC
NCT05690048Phase 2Recruiting
- Start
- Jul 2025
- Primary completion
- Mar 2028
- Modality
- Fresh FMT, Live Biotherapeutic Products, Frozen FMT
- Countries
- 1
01
Overview
A Phase 2 trial of INTESTIFIX 001 in hepatocellular carcinoma (HCC). Started Jul 2025; status: recruiting.
02
Drugs
INTESTIFIX 001
03
Conditions
hepatocellular carcinoma (HCC)
Beyond the preview
Go deeper on NCT05690048.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05690048.